{"nbformat":4,"nbformat_minor":0,"metadata":{"colab":{"provenance":[],"authorship_tag":"ABX9TyN5Km2kDaRKNGsexP03/Vr1"},"kernelspec":{"name":"python3","display_name":"Python 3"},"language_info":{"name":"python"}},"cells":[{"cell_type":"code","execution_count":null,"metadata":{"id":"EERRUcfw2zpA"},"outputs":[],"source":["import pandas as pd\n","import matplotlib.pyplot as plt\n","import seaborn as sns\n","import scipy.stats as stats"]},{"cell_type":"code","source":["sacubitril_valsartan_data = remaining_patient_data[remaining_patient_data['Group'] == 'Sacubitril-valsartan']\n","enalapril_data = remaining_patient_data[remaining_patient_data['Group'] == 'Enalapril']\n","characteristics = ['Height (cm)','Weight (kg)','Pre-treatment NT-proBNP (pg/mL)','Week 4 NT-proBNP (pg/mL)','Week 8 NT-proBNP (pg/mL)','Pre-treatment BNP (pg/mL)','Left ventricular ejection fraction (%)','BMI (kg/m^2)', ]"],"metadata":{"id":"76tA5QN524Pl"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["stats_sacubitril_valsartan = {}\n","stats_enalapril = {}"],"metadata":{"id":"mNLNi8Mt27sr"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["for char in characteristics:\n","    stats_sacubitril_valsartan[char] = {\n","        'mean': sacubitril_valsartan_data[char].mean(),\n","        'std': sacubitril_valsartan_data[char].std(),\n","        'median': sacubitril_valsartan_data[char].median()\n","    }\n","df_stats_sacubitril_valsartan = pd.DataFrame(stats_sacubitril_valsartan)\n","df_stats_sacubitril_valsartan"],"metadata":{"id":"KxlPGdQJ29JH"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["for char in characteristics:\n","    stats_enalapril[char] = {\n","        'mean': enalapril_data[char].mean(),\n","        'std': enalapril_data[char].std(),\n","        'median': enalapril_data[char].median()\n","    }\n","df_stats_enalapril = pd.DataFrame(stats_enalapril)\n","df_stats_enalapril"],"metadata":{"id":"vJP9Ih9Y2_FC"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["df_stats_enalapril.to_csv('df_stats_enalapril.csv', index=False)"],"metadata":{"id":"5_8buqTQ3Bbz"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["#1\n","'''\n","H0: There is no significant reduction in the mean NT-proBNP levels between pre-treatment and Week 4 in the sacubitril group.\n","H1: There is a significant reduction in the mean NT-proBNP levels between pre-treatment and Week 4 in the sacubitril group.\n","'''\n","sacubitril_data = remaining_patient_data[remaining_patient_data['Group'] == 'Sacubitril-valsartan']\n","stats.ttest_rel(sacubitril_data['Pre-treatment NT-proBNP (pg/mL)'],\n","                                       sacubitril_data['Week 4 NT-proBNP (pg/mL)'])"],"metadata":{"id":"kypU_gzD3EIm"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["#2\n","'''\n","H0: There is no significant reduction in the mean NT-proBNP levels between pre-treatment and Week 8 in the sacubitril group.\n","H1: There is a significant reduction in the mean NT-proBNP levels between pre-treatment and Week 8 in the sacubitril group.\n","'''\n","stats.ttest_rel(sacubitril_data['Pre-treatment NT-proBNP (pg/mL)'],\n","                                       sacubitril_data['Week 8 NT-proBNP (pg/mL)'])"],"metadata":{"id":"UCU1aPB93KG0"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["#3\n","'''\n","H0: There is no significant reduction in the mean NT-proBNP levels between pre-treatment and Week 4 in the Enalapril group.\n","H1: There is a significant reduction in the mean NT-proBNP levels between pre-treatment and Week 4 in the Enalapril group.\n","'''\n","enalapril_data = remaining_patient_data[remaining_patient_data['Group'] == 'Enalapril']\n","stats.ttest_rel(enalapril_data['Pre-treatment NT-proBNP (pg/mL)'],\n","                                      enalapril_data['Week 4 NT-proBNP (pg/mL)'])"],"metadata":{"id":"yGaZtOtY3May"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["#4\n","'''\n","H0: There is no significant reduction in the mean NT-proBNP levels between pre-treatment and Week 8 in the Enalapril group.\n","H1: There is a significant reduction in the mean NT-proBNP levels between pre-treatment and Week 8 in the Enalapril group.\n","'''\n","stats.ttest_rel(enalapril_data['Pre-treatment NT-proBNP (pg/mL)'],"],"metadata":{"id":"xzCWxavd3OpP"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["#5\n","'''\n","H0: There is no significant difference in the mean NT-proBNP levels at Week 4 between the sacubitril group and the enalapril group.\n","H1: There is a significant difference in the mean NT-proBNP levels at Week 4 between the sacubitril group and the enalapril group.\n","'''\n","week4_sacubitril = remaining_patient_data[remaining_patient_data['Group'] == 'Sacubitril-valsartan']['Week 4 NT-proBNP (pg/mL)']\n","week4_enalapril = remaining_patient_data[remaining_patient_data['Group'] == 'Enalapril']['Week 4 NT-proBNP (pg/mL)']\n","\n","stats.ttest_ind(week4_sacubitril, week4_enalapril)"],"metadata":{"id":"Qlxe-Wgj3Qfq"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["#6\n","'''\n","H0: There is no significant difference in the mean NT-proBNP levels at Week 8 between the sacubitril group and the enalapril group.\n","H1: There is a significant difference in the mean NT-proBNP levels at Week 8 between the sacubitril group and the enalapril group.\n","'''\n","week8_sacubitril = remaining_patient_data[remaining_patient_data['Group'] == 'Sacubitril-valsartan']['Week 8 NT-proBNP (pg/mL)']\n","week8_enalapril = remaining_patient_data[remaining_patient_data['Group'] == 'Enalapril']['Week 8 NT-proBNP (pg/mL)']\n","\n","stats.ttest_ind(week8_sacubitril, week8_enalapril)"],"metadata":{"id":"XXjyCf7z3SSG"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["#7\n","older_participants = remaining_patient_data[remaining_patient_data['Age'] >= 60]\n","week4_sacubitril_older = older_participants[older_participants['Group'] == 'Sacubitril-valsartan']['Week 4 NT-proBNP (pg/mL)']\n","week4_enalapril_older = older_participants[older_participants['Group'] == 'Enalapril']['Week 4 NT-proBNP (pg/mL)']\n","stats.ttest_ind(week4_sacubitril_older, week4_enalapril_older)"],"metadata":{"id":"WQ2qE2zJ3UDD"},"execution_count":null,"outputs":[]},{"cell_type":"code","source":["#8\n","week8_sacubitril_older = older_participants[older_participants['Group'] == 'Sacubitril-valsartan']['Week 8 NT-proBNP (pg/mL)']\n","week8_enalapril_older = older_participants[older_participants['Group'] == 'Enalapril']['Week 8 NT-proBNP (pg/mL)']\n","stats.ttest_ind(week8_sacubitril_older, week8_enalapril_older)"],"metadata":{"id":"zA7TF2E23Vk6"},"execution_count":null,"outputs":[]}]}